drugset / Trial / NCT00097747
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and minimum pharmacologically active dose of peginesatide in Healthy Volunteers.
Timeline
- Start
- 2004-08
- Primary completion
- 2005-01
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | peginesatide | Peptide | 0.025 mg/kg | Intravenous |
| Subject | peginesatide | Peptide | 0.05 mg/kg | Intravenous |
| Subject | peginesatide | Peptide | 0.1 mg/kg | Intravenous |